Haruhiko Hirata

Identification of CD72 as a Lymphocyte Receptor for the Class IV Semaphorin CD100

Atsushi Kumanogoh, Chie Watanabe, Ihn-Sook Lee et al. · Immunity · 2000 · 363 citations · Full text

Life Sciences, Cell Biology, Immunology +10

Clinical implications of monitoring nivolumab immunokinetics in non–small cell lung cancer patients

Akio Osa, Takeshi Uenami, Shohei Koyama et al. · JCI Insight · 2018 · 234 citations · Full text

Pharmacy, Immunology, Oncology +17

Impact of sarcopenia in patients with advanced non–small cell lung cancer treated with PD-1 inhibitors: A preliminary retrospective study

Takayuki Shiroyama, Izumi Nagatomo, Shohei Koyama et al. · Scientific Reports · 2019 · 164 citations · Full text

Medicine, Oncology, Pharmacology +17

DOCK2 is involved in the host genetics and biology of severe COVID-19

Ho Namkoong, Ryuya Edahiro, Tomomi Takano et al. · Nature · 2022 · 97 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Early [18F]Fluorodeoxyglucose Positron Emission Tomography at Two Days of Gefitinib Treatment Predicts Clinical Outcome in Patients with Adenocarcinoma of the Lung

Ryo Takahashi, Haruhiko Hirata, Isao Tachibana et al. · Clinical Cancer Research · 2011 · 91 citations

Medicine, Radiology, Diagnostic Radiology +15